Tempus AI (NASDAQ:TEM) Price Target Raised to $47.00

Tempus AI (NASDAQ:TEM) had its price objective increased by equities researchers at JPMorgan Chase & Co. from $42.00 to $47.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target suggests a potential upside of 18.99% from the company’s previous close.

A number of other brokerages have also recently commented on TEM. Morgan Stanley initiated coverage on shares of Tempus AI in a research note on Tuesday, July 9th. They issued an “overweight” rating and a $44.00 price objective for the company. Needham & Company LLC reaffirmed a “buy” rating and set a $47.00 price target on shares of Tempus AI in a research note on Wednesday. TD Cowen assumed coverage on shares of Tempus AI in a research report on Tuesday, July 9th. They issued a “buy” rating and a $50.00 price objective for the company. Loop Capital initiated coverage on shares of Tempus AI in a research report on Tuesday, July 9th. They issued a “buy” rating and a $48.00 price objective for the company. Finally, Stifel Nicolaus initiated coverage on shares of Tempus AI in a report on Tuesday, July 9th. They issued a “buy” rating and a $45.00 price target for the company. Nine analysts have rated the stock with a buy rating, According to MarketBeat, the company has a consensus rating of “Buy” and an average price target of $46.25.

Tempus AI Trading Down 2.8 %

NASDAQ TEM traded down $1.15 on Wednesday, reaching $39.50. The company had a trading volume of 808,888 shares, compared to its average volume of 1,255,705. Tempus AI has a 12 month low of $22.89 and a 12 month high of $47.09.

Institutional Trading of Tempus AI

Several large investors have recently bought and sold shares of TEM. Alphabet Inc. purchased a new stake in shares of Tempus AI in the 2nd quarter valued at $54,289,000. ARK Investment Management LLC acquired a new position in Tempus AI during the second quarter worth $18,294,000. EFG Asset Management North America Corp. acquired a new position in Tempus AI during the second quarter worth $1,333,000. Finally, Northwestern University acquired a new position in Tempus AI during the second quarter worth $491,000.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.